camptothecin has been researched along with Vascular Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Di Bartolo, BA; Kavurma, MM; Mattar, MZ; Rachner, TD; Schoppet, M; Shanahan, CM | 1 |
Meropol, NJ; Poplin, EA; Rothenberg, ML; Van Cutsem, E; Wadler, S | 1 |
2 other study(ies) available for camptothecin and Vascular Diseases
Article | Year |
---|---|
Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification.
Topics: Animals; Apoptosis; Calcinosis; Calcium; Camptothecin; Cells, Cultured; Feedback, Physiological; Gene Expression Regulation; Humans; Muscle, Smooth, Vascular; Mutation; Myocytes, Smooth Muscle; NF-kappa B; Osteoprotegerin; Proto-Oncogene Proteins c-bcl-2; Rats; Receptor, IGF Type 1; RNA Interference; RNA, Messenger; Sp1 Transcription Factor; Time Factors; Transfection; Vascular Diseases | 2011 |
Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cause of Death; Fluorouracil; Gastrointestinal Diseases; Guidelines as Topic; Irinotecan; Leucovorin; Mortality; Randomized Controlled Trials as Topic; Risk Factors; Syndrome; Time Factors; Vascular Diseases | 2001 |